LabGenomics Co., Ltd. (KOSDAQ:084650)
South Korea · Delayed Price · Currency is KRW 864.00
-32.00 (-3.57%)
Jun 5, 2026, 3:30 PM KST
LabGenomics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -63,708 | -64,375 | -23,796 | -4,674 | 48,397 | 83,855 |
Depreciation & Amortization | 9,324 | 10,311 | 9,599 | 5,896 | 3,965 | 3,340 |
Loss (Gain) From Sale of Assets | 11.69 | 90.34 | 252.63 | -1,409 | 47.05 | - |
Asset Writedown & Restructuring Costs | 6,615 | 6,615 | 9,471 | - | - | 55.2 |
Loss (Gain) From Sale of Investments | 1,011 | 1,369 | 2,050 | -1,016 | 3,959 | -2,436 |
Loss (Gain) on Equity Investments | 125.63 | 127.05 | 396.84 | 677.78 | 72.11 | 46.37 |
Stock-Based Compensation | -283.43 | 7.25 | 501.31 | 16.15 | 47.94 | 31.78 |
Provision & Write-off of Bad Debts | 37,621 | 37,651 | 548.91 | 1,486 | 174.16 | -33.5 |
Other Operating Activities | 5,804 | 5,180 | -10,027 | 229.79 | -17,441 | 11,708 |
Change in Accounts Receivable | -23,946 | -25,942 | 944.81 | 11,867 | 36,609 | -36,873 |
Change in Inventory | 626.48 | -365.77 | -1,377 | 243.12 | 2,505 | 2,088 |
Change in Accounts Payable | -1,645 | 678.94 | -1,563 | -7,802 | -8,427 | 3,296 |
Change in Unearned Revenue | -17.22 | -22.4 | 39.85 | 10.47 | - | - |
Change in Income Taxes | 446.13 | 405.22 | 2,603 | -2,912 | - | - |
Change in Other Net Operating Assets | -479.39 | -2,266 | -2,640 | -6,442 | -955.03 | 284.83 |
Operating Cash Flow | -28,494 | -30,536 | -12,995 | -3,827 | 68,955 | 65,362 |
Operating Cash Flow Growth | - | - | - | - | 5.50% | 40.95% |
Capital Expenditures | -1,257 | -1,138 | -3,669 | -4,990 | -37,648 | -13,717 |
Sale of Property, Plant & Equipment | 258.41 | 258.03 | 157.12 | 7,582 | - | 19.1 |
Cash Acquisitions | - | - | -9,835 | -77,191 | - | - |
Divestitures | 393.8 | 393.8 | - | 6,020 | - | - |
Sale (Purchase) of Intangibles | -536.99 | -525.41 | -878.92 | -206.59 | -682.26 | -97.83 |
Investment in Securities | 12,527 | 15,644 | 9,065 | -41,302 | -14,940 | -15,741 |
Other Investing Activities | 402.86 | 408.56 | 2,042 | -204.62 | -47.95 | 3,476 |
Investing Cash Flow | 11,830 | 15,041 | -3,762 | -110,355 | -53,317 | -26,061 |
Long-Term Debt Issued | - | 142.22 | - | 40,000 | 16,000 | 3,200 |
Short-Term Debt Repaid | - | - | - | - | - | -2,500 |
Long-Term Debt Repaid | - | -2,210 | -2,276 | -4,993 | -1,237 | -1,351 |
Total Debt Repaid | -2,085 | -2,210 | -2,276 | -4,993 | -1,237 | -3,851 |
Net Debt Issued (Repaid) | 2,204 | -2,068 | -2,276 | 35,007 | 14,763 | -650.63 |
Issuance of Common Stock | - | - | - | 22,712 | - | - |
Repurchase of Common Stock | - | - | - | - | - | -6,543 |
Dividends Paid | - | - | - | - | -3,317 | - |
Other Financing Activities | 3 | 3 | 47.1 | -72.7 | -0 | - |
Financing Cash Flow | 2,207 | -2,065 | -2,229 | 57,646 | 11,445 | -7,194 |
Foreign Exchange Rate Adjustments | -70.4 | -187.63 | 1,171 | 349.43 | -14.3 | -131.83 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 913.97 | 718.62 |
Net Cash Flow | -14,526 | -17,748 | -17,814 | -56,186 | 27,982 | 32,694 |
Free Cash Flow | -29,751 | -31,674 | -16,663 | -8,817 | 31,307 | 51,645 |
Free Cash Flow Growth | - | - | - | - | -39.38% | 13.08% |
Free Cash Flow Margin | -35.34% | -35.93% | -19.40% | -12.40% | 21.63% | 25.52% |
Free Cash Flow Per Share | -400.64 | -426.64 | -225.48 | -118.76 | 462.30 | 764.15 |
Cash Interest Paid | 1,974 | 1,898 | 1,763 | 1,658 | 498.73 | 118.93 |
Cash Income Tax Paid | 235 | 152.26 | 4,594 | 3,874 | 32,565 | 11,929 |
Levered Free Cash Flow | -1,591 | -7,368 | -14,099 | 799.5 | 20,219 | 35,699 |
Unlevered Free Cash Flow | 2,108 | -3,787 | -10,657 | 3,895 | 20,578 | 35,829 |
Change in Working Capital | -25,015 | -27,512 | -1,991 | -5,035 | 29,733 | -31,204 |